Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MGNI
|
Katie Seitz Evans
President, Operations |
SELL
Open market or private sale
|
Direct | 12,520 Reduced 2.48% |
$250,400
$20.0 p/Share
|
Feb 07
2025 |
|
MGNI
|
Sean Patrick Buckley
President, Revenue |
SELL
Open market or private sale
|
Direct | 18,693 Reduced 4.38% |
$373,860
$20.0 p/Share
|
Feb 07
2025 |
|
MGNI
|
James Rossman |
SELL
Open market or private sale
|
Direct | 149,936 Reduced 40.54% |
$2,917,754
$19.46 p/Share
|
Feb 07
2025 |
|
NFLX
|
Gregory K Peters
Co-CEO |
SELL
Open market or private sale
|
Direct | 10,152 Reduced 43.94% |
$10,380,420
$1022.5 p/Share
|
Feb 07
2025 |
|
MGNI
|
David Day
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 39,000 Reduced 7.39% |
$780,000
$20.0 p/Share
|
Feb 07
2025 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,523,490
$317.5 p/Share
|
Feb 07
2025 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,948 Reduced 0.0% |
$2,523,490
$317.5 p/Share
|
Feb 07
2025 |
|
CASK
|
Jennifer D H Stiefel
President & Secretary |
BUY
Open market or private purchase
|
Indirect | 2,916 Added 0.0% |
$3,499
$1.2 p/Share
|
Feb 07
2025 |
|
CASK
|
Jennifer D H Stiefel
President & Secretary |
BUY
Open market or private purchase
|
Direct | 2,450 Added 3.51% |
$3,013
$1.23 p/Share
|
Feb 07
2025 |
|
CASK
|
Justin B Stiefel
CEO & Treasurer |
BUY
Open market or private purchase
|
Indirect | 2,450 Added 0.0% |
$3,013
$1.23 p/Share
|
Feb 07
2025 |
|
CASK
|
Justin B Stiefel
CEO & Treasurer |
BUY
Open market or private purchase
|
Direct | 2,916 Added 6.27% |
$3,499
$1.2 p/Share
|
Feb 07
2025 |
|
TEM
|
Eric P Lefkofsky
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 80,388 Reduced 1.5% |
$5,450,306
$67.8 p/Share
|
Feb 07
2025 |
|
IBEX
|
Paul Joseph Inson
Chief People Officer |
SELL
Open market or private sale
|
Direct | 1,956 Reduced 27.13% |
$48,900
$25.0 p/Share
|
Feb 07
2025 |
|
CSL
|
Jonathan R. Collins
Director |
SELL
Open market or private sale
|
Direct | 1,050 Reduced 28.26% |
$366,702
$349.24 p/Share
|
Feb 07
2025 |
|
IBEX
|
Bruce Neil Dawson
Chief Sales and CS Officer |
SELL
Open market or private sale
|
Direct | 13,500 Reduced 70.65% |
$324,000
$24.0 p/Share
|
Feb 07
2025 |
|
JCI
|
George Oliver
Chairman & CEO |
SELL
Open market or private sale
|
Direct | 205,168 Reduced 14.0% |
$18,114,282
$88.29 p/Share
|
Feb 07
2025 |
|
INSM
|
John Drayton Wise
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 10 Reduced 0.01% |
$789
$78.91 p/Share
|
Feb 07
2025 |
|
INSM
|
Roger Adsett
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 100 Reduced 0.05% |
$7,956
$79.57 p/Share
|
Feb 07
2025 |
|
INSM
|
Martina M.D. Flammer
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 60 Reduced 0.04% |
$4,775
$79.59 p/Share
|
Feb 07
2025 |
|
IBEX
|
Mohammedulla Khaishgi
Director |
SELL
Open market or private sale
|
Indirect | 10,000 Reduced 0.0% |
$225,500
$22.55 p/Share
|
Feb 07
2025 |
|
IBEX
|
Mohammedulla Khaishgi
Director |
SELL
Open market or private sale
|
Direct | 12,600 Reduced 6.2% |
$283,500
$22.5 p/Share
|
Feb 07
2025 |
|
IBEX
|
Robert Thomas Dechant
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 2,621 Reduced 1.17% |
$65,525
$25.0 p/Share
|
Feb 07
2025 |
|
TTSH
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 19,000 Added 0.0% |
$140,410
$7.39 p/Share
|
Feb 07
2025 |
|
FLWS
|
Fund 1 Investments, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 265,500 Added 0.0% |
$2,134,620
$8.04 p/Share
|
Feb 07
2025 |
|
ICHR
|
Jorge Titinger
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 23.38% |
$96,120
$32.04 p/Share
|
Feb 07
2025 |
|
WM
|
Rafael Carrasco
SVP of Enterprise Strategy |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 17.75% |
$903,560
$225.89 p/Share
|
Feb 07
2025 |
|
HLT
|
Christopher J Nassetta
Director |
SELL
Open market or private sale
|
Direct | 40,653 Reduced 34.44% |
$10,928,745
$268.83 p/Share
|
Feb 07
2025 |
|
PM
|
Frederic De Wilde
Pr SSEA CIS & MEA Region |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 10.42% |
$2,168,100
$144.54 p/Share
|
Feb 07
2025 |
|
MKL
|
Thomas Sinnickson Gayner
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 100 Added 0.2% |
$200,801
$2008.01 p/Share
|
Feb 07
2025 |
|
V
|
Tullier Kelly Mahon
VICE CHAIR, CHF PPL & CORP AFF |
SELL
Open market or private sale
|
Direct | 33,741 Reduced 47.99% |
$11,801,589
$349.77 p/Share
|
Feb 07
2025 |
|
V
|
Peter M Andreski
GBL CORP CONTROLLER, CAO |
SELL
Open market or private sale
|
Direct | 2,332 Reduced 34.19% |
$815,313
$349.62 p/Share
|
Feb 07
2025 |
|
FBP
|
Carlos Power
EVP |
SELL
Open market or private sale
|
Direct | 10,321 Reduced 5.53% |
$214,160
$20.75 p/Share
|
Feb 07
2025 |
|
PGY
|
Tami Rosen
Chief Development Officer |
SELL
Open market or private sale
|
Direct | 9,846 Reduced 11.81% |
$119,924
$12.18 p/Share
|
Feb 07
2025 |
|
CBKM
|
John W Parkinson
Director |
BUY
Open market or private purchase
|
Direct | 300 Added 1.72% |
$5,733
$19.11 p/Share
|
Feb 07
2025 |
|
CBKM
|
Shawna L'Italien
Director |
BUY
Open market or private purchase
|
Direct | 525 Added 8.83% |
$10,027
$19.1 p/Share
|
Feb 07
2025 |
|
NWFL
|
Ronald R Schmalzle |
BUY
Open market or private purchase
|
Indirect | 2,800 Added 0.0% |
$74,172
$26.49 p/Share
|
Feb 07
2025 |
|
MSBI
|
Gerald Joseph Carlson |
BUY
Open market or private purchase
|
Direct | 2,000 Added 33.33% |
$39,940
$19.97 p/Share
|
Feb 07
2025 |
|
NBTB
|
Heidi M Hoeller
Director |
BUY
Open market or private purchase
|
Direct | 678 Added 9.53% |
$32,849
$48.45 p/Share
|
Feb 07
2025 |
|
FNWD
|
Benjamin Louis Schmitt
Chief Financial Officer |
SELL
Open market or private purchase
|
Direct | 500 Reduced 11.11% |
$13,500
$27.0 p/Share
|
Feb 07
2025 |
|
ZNTL
|
Ingmar Bruns
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 20,000 Added 35.32% |
$45,599
$2.28 p/Share
|
Feb 06
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$25,700
$12.85 p/Share
|
Feb 06
2025 |
|
LTRYW
|
Robert J Stubblefield
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 7.02% |
$24,600
$1.23 p/Share
|
Feb 06
2025 |
|
THFF
|
Susan M Jensen |
BUY
Open market or private purchase
|
Direct | 62 Added 3.08% |
$3,220
$51.95 p/Share
|
Feb 06
2025 |
|
ANET
|
Kenneth Duda
CTO and SVP Software Eng. |
SELL
Open market or private sale
|
Direct | 80,000 Reduced 86.04% |
$9,268,800
$115.86 p/Share
|
Feb 06
2025 |
|
ANET
|
Kenneth Duda
CTO and SVP Software Eng. |
SELL
Open market or private sale
|
Indirect | 80,000 Reduced 0.0% |
$9,268,800
$115.86 p/Share
|
Feb 06
2025 |
|
OCX
|
Broadwood Partners, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Feb 06
2025 |
|
OCX
|
Broadwood Partners, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 5,165,695 Added 31.16% |
$10,589,674
$2.05 p/Share
|
Feb 06
2025 |
|
BENF
|
Jeff Welday
Officer |
SELL
Open market or private sale
|
Direct | 136 Reduced 0.09% |
$80
$0.59 p/Share
|
Feb 06
2025 |
|
ARES
|
R. Kipp De Veer
Co-President |
SELL
Open market or private sale
|
Direct | 78,933 Reduced 6.42% |
$14,957,803
$189.5 p/Share
|
Feb 06
2025 |
|
ABC
|
Walgreens Boots Alliance, Inc. |
SELL
Open market or private sale
|
Indirect | 1,286,376 Reduced 0.0% |
$314,531,795
$244.51 p/Share
|
Feb 06
2025 |